FGFR1 has seven alternative promoters supported by curated full-length c-DNA clones, and at least of four of them have been shown to control the differential expression in a tissue- and cancer cell- specific manner [27], [28], [29], [30]. The gene discussed is FGFR1; the disease is cancer.